Wirkstoffe nach Zahlen: reaktionsbasierter De-novo-Entwurf von potenten und selektiven Leitstrukturen für die Krebsforschung
Authors:
- Birgit SpänkuchBSBirgit Spänkuch
- Gisbert SchneiderGSGisbert Schneider
- 20 November 2012
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 125 (17) , 4774-4779
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- DOGS: Reaction-Driven de novo Design of Bioactive CompoundsPLOS Computational Biology, 2012
- Quantifying the chemical beauty of drugsNature Chemistry, 2012
- Drug discovery in the next decade: innovation needed ASAPDrug Discovery Today, 2011
- PLK1 as an oncology target: current status and future potentialDrug Discovery Today, 2011
- Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces−A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding ProfilesJournal of Chemical Information and Computer Sciences, 2003
- The Protein Data BankNucleic Acids Research, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Molecular recognition of receptor sites using a genetic algorithm with a description of desolvationJournal of Molecular Biology, 1995
- A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamineLife Sciences, 1974